These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23702669)

  • 1. Distinctive stages and strain variations of A. baumannii biofilm development under shear flow.
    Feng SH; Stojadinovic A; Izadjoo M
    J Wound Care; 2013 Apr; 22(4):173-4, 176-8, 180-1. PubMed ID: 23702669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adhesion and slime production by wild and clinical strains of Acinetobacter baumannii].
    Jachna-Sawicka K; Kleszczyńska M; Gospodarek E
    Med Dosw Mikrobiol; 2012; 64(3):221-8. PubMed ID: 23285776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters.
    Pour NK; Dusane DH; Dhakephalkar PK; Zamin FR; Zinjarde SS; Chopade BA
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):328-38. PubMed ID: 21569125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces.
    Greene C; Wu J; Rickard AH; Xi C
    Lett Appl Microbiol; 2016 Oct; 63(4):233-9. PubMed ID: 27479925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces.
    Espinal P; Martí S; Vila J
    J Hosp Infect; 2012 Jan; 80(1):56-60. PubMed ID: 21975219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.
    Liu Y; Mi Z; Niu W; An X; Yuan X; Liu H; Wang Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Li P; Tong Y; Bai C
    Future Microbiol; 2016 Oct; 11():1383-1393. PubMed ID: 27538011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals.
    Wroblewska MM; Sawicka-Grzelak A; Marchel H; Luczak M; Sivan A
    FEMS Immunol Med Microbiol; 2008 Jun; 53(1):140-4. PubMed ID: 18400015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.
    Lee HW; Koh YM; Kim J; Lee JC; Lee YC; Seol SY; Cho DT; Kim J
    Clin Microbiol Infect; 2008 Jan; 14(1):49-54. PubMed ID: 18005176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BioFlux™ 200 Microfluidic System to Study A. baumannii Biofilm Formation in a Dynamic Mode of Growth.
    Naudin B; Heins A; Pinhal S; Dé E; Nicol M
    Methods Mol Biol; 2019; 1946():167-176. PubMed ID: 30798554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of pH effects on the bacterial surface physicochemical properties of Acinetobacter baumannii.
    Djeribi R; Boucherit Z; Bouchloukh W; Zouaoui W; Latrache H; Hamadi F; Menaa B
    Colloids Surf B Biointerfaces; 2013 Feb; 102():540-5. PubMed ID: 23104023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
    Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
    Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.
    King LB; Swiatlo E; Swiatlo A; McDaniel LS
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):414-21. PubMed ID: 19220466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm.
    Yele AB; Thawal ND; Sahu PK; Chopade BA
    Arch Virol; 2012 Aug; 157(8):1441-50. PubMed ID: 22552486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput microfluidic method to study biofilm formation and host-pathogen interactions in pathogenic Escherichia coli.
    Tremblay YD; Vogeleer P; Jacques M; Harel J
    Appl Environ Microbiol; 2015 Apr; 81(8):2827-40. PubMed ID: 25681176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotic and abiotic substrates for enhancing Acinetobacter baumannii biofilm formation: New approach using extracellular matrix and slanted coverslip technique.
    Ramalingam K; Lee V
    J Gen Appl Microbiol; 2019 May; 65(2):64-71. PubMed ID: 30224574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system.
    Tomaras AP; Dorsey CW; Edelmann RE; Actis LA
    Microbiology (Reading); 2003 Dec; 149(Pt 12):3473-3484. PubMed ID: 14663080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into acinetobacter war-wound infections, biofilms, and control.
    Dallo SF; Weitao T
    Adv Skin Wound Care; 2010 Apr; 23(4):169-74. PubMed ID: 20299843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Simple Static Biofilm Assay for Acinetobacter baumannii.
    Biswas I; Mettlach J
    Methods Mol Biol; 2019; 1946():159-165. PubMed ID: 30798553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planktonic replication is essential for biofilm formation by Legionella pneumophila in a complex medium under static and dynamic flow conditions.
    Mampel J; Spirig T; Weber SS; Haagensen JA; Molin S; Hilbi H
    Appl Environ Microbiol; 2006 Apr; 72(4):2885-95. PubMed ID: 16597995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients' respiratory tract sources.
    Obeidat N; Jawdat F; Al-Bakri AG; Shehabi AA
    Am J Infect Control; 2014 Apr; 42(4):401-4. PubMed ID: 24679567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.